Chemotherapy-induced peripheral neuropathy; its impact on colorectal cancer patients' lives

Completed

• Conditions: Colorectal cancer; colorectal carcinoma; 10017990; 10017991

• Registration Number: NL-OMON43710
• Lead Sponsor: Integraal Kankercentrum Nederland, locatie Eindhoven

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 2021-12-24
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 800

Inclusion Criteria

- Diagnosed with colorectal cancer
- 18 years or older

Exclusion Criteria

- Patients with cognitive impairment will not be included because of expected difficulties in completing these questionnaires without assistance.
- Patients who are not able to read or write Dutch will be excluded, as they are not able to
complete a Dutch questionnaire.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Neuropathy, health-related quality of life, disease-specific complaints,<br /><br>depression, fatigue, sleep problems, personality, comorbidity, physical<br /><br>activity, health care utilisation, health supplement use, employment, genetic<br /><br>and biological markers including pro-and anti-inflammatory cytokines (IL-1&beta;,<br /><br>IL-6, TNF-a, IL-RN, and IL-10) genes. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>